Bill Title: Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2023-05-01 - Left pending in committee [HB2529 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2023-02-21	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for Texas HB2529

Supplemental Documents

Title	Description	Date	Format	Source	View
Fiscal Note	Fiscal Note (Introduced)	2023-04-27	HTML/Text	Link	View

Social Comments on TX HB2529